Abstract:Numerous molecular abnormalities have been described in lymphomas. They are of diagnostic and prognostic value and are taken into account for the WHO classification of these tumors. They also shed some light on the underlying molecular mechanisms involved in lymphomas. Overall, four types of molecular abnormalities are involved: mutations, translocations, amplifications and deletions of tumor suppressor genes. Several techniques are available to detect these molecular anomalies: conventional cytogenetic analysis, multicolor FISH, CGH array or gene expression profiling using DNA microarrays. In some lymphomas, genetic abnormalities are responsible for the expression of an abnormal protein (e.g. tyrosine-kinase, transcription factor) detectable by immunohistochemistry. In the present review, molecular abnormalities observed in the most frequent B, T or NK cell lymphomas are discussed. In the broad spectrum of diffuse large B-cell lymphomas microarray analysis shows mostly two subgroups of tumors, one with gene expression signature corresponding to germinal center B-cell-like (GCB: CD10+, BCL6 [B-Cell Lymphoma 6]+, centerine+, MUM1-) and a subgroup expressing an activated B-cell-like signature (ABC: CD10-, BCL6-, centerine-, MUM1+). Among other B-cell lymphomas with well characterized molecular abnormalies are follicular lymphoma (BCL2 deregulation), MALT lymphoma (Mucosa Associated Lymphoid Tissue) [API2-MALT1 (mucosa-associated-lymphoid-tissue-lymphoma-translocation-gene1) fusion protein or deregulation BCL10, MALT1, FOXP1. MALT1 transcription factors], mantle cell lymphoma (cycline D1 [CCND1] overexpression) and Burkitt lymphoma (c-Myc expression). Except for ALK (anaplastic lymphoma kinase)-positive anaplastic large cell lymphoma, well characterized molecular anomalies are rare in lymphomas developed from T or NK cells. Peripheral T cell lymphomas not otherwise specified are a heterogeneous group of tumors with frequent but not recurrent molecular abnormalities. Gene profiling analysis shows that the expression of several genes is deregulated including PDGFRA (platelet-derived growth factor receptor) gene, encoding a receptor with tyrosine kinase activity. In angio-immunoblastic T-cell lymphomas molecular abnormalities are found in follicular helper T-cell (TFH) that express some distinctive markers such as CD10, PD-1, CXCR5 and the CXCL13 chemokine. ALK-positive anaplastic large cell lymphoma is a paradigme of T-cell lymphoma since it is associated with an X-ALK oncogenic fusion protein due to a translocation involving ALK gene at 2p23. ALK tyrosine kinase activates downstream pathways (Stat3/5b, Src kinases, PLCγ, PI3 kinase) implicated in lymphomagenesis, proliferation and protection against apoptosis. Specific ALK inhibitors are currently in clinical evaluation. Lastly several lymphomas are associated with infectious agents that play a direct (EB virus, HTLV1) or indirect role (e.g. Helicobacter pylori in MALT lymphoma) in lymphomagenesis.

Progress on the Study of Molecular Genetics of MALT Lymphomas

Recent Advances in the Genetic of MALT Lymphomas

[A Clinical Study of Chromosome Translocations in Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Chinese Patients].

[Research Progress on the Etiology and Pathogenesis of MALT Lymphoma].

Malt Lymphoma with T(14;18)(Q32;Q21)/Igh-Malt1 is Characterized by Strong Cytoplasmic Malt1 and Bcl10 Expression

[Frequency of Genetic Aberrations in Mucosa-Associated Lymphoid Tissue Lymphoma of Different Sites].

[High Incidence of T (11; 18)/API2-MALT1 and BCL10 Aberrant Nuclear Expression in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphomas].

Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites

Higher Rates Of T(11;18) In Chinese Patients With Transformed Type Of Malt Lymphoma Suggest Novel Pathways For Progression Of The Disease

[Expression of T(11;18) and Bcl-10 in Gastrointestinal MALT Lymphoma].

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from (auto)antigen driven selection to the activation of NF-κB signaling

Pathological Features, IgM Expression and MYD88 L265P Mutation in MALT Lymphoma

Study on the Relationship Between Protein Expression and Gene Abnormalities of Myc, Bcl-2 and Bcl-6In Diffuse Large B-cell Lymphoma

Research Progress on Prognostic Markers of Chronic Lymphocytic Leukemia

[Acquired Somatic Mutations in Non-Coding Region of Bcl-6 Gene in Germinal Center-Type Diffuse Large B-cell Lymphoma].

[Molecular abnormalities in lymphomas]

The genetic landscape of histologically transformed marginal zone lymphomas

[Analysis of 37 Pathological and Clinic Data of Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT)].

Diagnosis of Pulmonary MALT Lymphomas by Combined the Characteristics of Radiology, Histopathology and Immunohischemistry

Clinical progress and pathological features of mucosa-associated lymphoid tissue lymphoma

Significance of t(14;18) Translocation and BCL2 Expression in Diffuse Large B-cell Lymphoma